Afluria® Quadrivalent (influenza vaccine) – Expanded indication
August 31, 2017 – The FDA approved Seqirus’ Afluria Quadrivalent (influenza vaccine) for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine in persons 5 years of age and older.
Top